Potential treatment for psoriasis to be commercially developed under worldwide patent deal
- 6 August 2014
- Research
- Innovation
An anti-inflammatory peptide discovered by David Greaves and his group in the Dunn School of Pathology will be tested for its ability to treat psoriasis following a licensing deal between the University of Oxford’s ISIS Innovation and San Francisco start-up Rogne Biosciences.